Skip to main content
Yixintang Pharmaceutical Group Co., Ltd. logo

Yixintang Pharmaceutical Group Co., Ltd. — Investor Relations & Filings

Ticker · 002727 ISIN · CNE100001WJ8 LEI · 300300NE1YJT00E9JD69 Shenzhen Stock Exchange Wholesale and retail trade
Open in API
Filings indexed 2,825 across all filing types
Latest filing 2025-11-13 Declaration of Voting R…
Country CN China
Listing Shenzhen Stock Exchange 002727

About Yixintang Pharmaceutical Group Co., Ltd.

https://www.hx8886.com

Yixintang Pharmaceutical Group Co., Ltd. operates an extensive network of retail pharmacies providing a broad spectrum of healthcare products and services. The company specializes in the distribution of Western pharmaceuticals, traditional Chinese medicine (TCM), medical equipment, and health supplements. Its operational model integrates physical storefronts with digital platforms to facilitate online-to-offline (O2O) services, including prescription fulfillment and health consultations. Key offerings include chronic disease management, professional pharmaceutical advice, and a diverse inventory of over-the-counter (OTC) medications. The company focuses on community-based health accessibility, utilizing a robust supply chain to ensure product quality and availability across its service regions.

Recent filings

Filing Released Lang Actions
2025年度第三次临时股东会暨中小投资者表决结果公告
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is an announcement of the voting results from a shareholders' meeting, specifically the 2025 third extraordinary general meeting of shareholders of Yixintang Pharmaceutical Group Co., Ltd. It details the meeting date, attendance, voting procedures, and the results of various proposals including election of board members and amendments to company bylaws. There is no financial data or report content, only the official voting outcomes and legal opinions on the meeting's validity. This matches the definition of 'Declaration of Voting Results & Voting Rights Announcements (DVA)'. The document length is over 5,000 characters and contains detailed voting results, confirming it is not a mere announcement of a report publication but the actual voting results disclosure.
2025-11-13 Chinese
关于使用部分暂时闲置自有资金进行现金管理的进展公告
Capital/Financing Update Classification · 95% confidence The document is an announcement from a company about the progress of using temporarily idle funds for cash management, including details of investment products, risk analysis, and past 12 months' cash management activities. It is a regulatory disclosure about financing activities related to cash management and investment products, not a full financial report or earnings release. The document is about capital usage and investment updates, fitting the Capital/Financing Update category. It is not an annual or interim report, audit report, or earnings release. The length and content indicate it is a substantive announcement rather than a brief notice or certification. Therefore, the appropriate classification is Capital/Financing Update (CAP).
2025-11-12 Chinese
关于全资子公司广西鸿翔一心堂药业有限责任公司向银行申请授信额度提供担保的进展公告
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding the progress of a guarantee provided by the parent company to its wholly-owned subsidiary for a bank credit facility. It details the guarantee amount, the subsidiary's financial status, the guarantee agreement, and the rationale for the guarantee. There are no financial statements or comprehensive financial reports included. The document is a formal disclosure of a financing-related guarantee arrangement, which fits the category of Capital/Financing Update (CAP). The document length is under 5,000 characters and it is not a report publication announcement or certification. Therefore, the appropriate classification is CAP with high confidence.
2025-11-12 Chinese
关于使用部分暂时闲置自有资金进行现金管理的进展公告
Capital/Financing Update Classification · 95% confidence The document is an announcement from a company about the progress of using temporarily idle funds for cash management, including details of agreements with banks, investment products, risk analysis, and the impact on the company. It includes tables of investment amounts, product types, contract dates, and returns. The document is a formal disclosure to shareholders and the market about cash management activities, not a financial report or earnings release. It does not contain comprehensive financial statements or detailed management discussion of financial results. It is not a report publication announcement since it contains substantive information rather than just a notice of report availability. The content fits best with a Capital/Financing Update (CAP) as it relates to the company's use of funds and investment activities in cash management products.
2025-11-10 Chinese
关于实际控制人内部转让公司股份的提示性公告
Major Shareholding Notification Classification · 95% confidence The document is a public announcement regarding an internal transfer of shares between the actual controller and his daughters. It details the shareholder's name, shareholding percentages, transfer plan, and regulatory compliance. There is no financial data, earnings information, or report attached. The document is a notification about a shareholding change within the controlling family, which fits the category of Major Shareholding Notification (MRQ). The document length is short (1929 characters), and it is not a report or a certification but a formal announcement of share transfer plans and related disclosures.
2025-11-06 Chinese
关于全资子公司重庆鸿翔一心堂药业有限公司向银行申请授信额度提供担保的进展公告
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding the progress of a guarantee provided by the parent company to its wholly-owned subsidiary for a bank credit facility. It includes details about the guarantee amount, the subsidiary's financial status, and the guarantee contract. The document is relatively short (2905 characters) and focuses on a specific financing guarantee event rather than a full financial report or audit. It does not contain comprehensive financial statements or detailed financial analysis. Therefore, it is best classified as a Capital/Financing Update (CAP), which covers updates on company financing activities or capital structure changes.
2025-11-03 Chinese

Browse filings by year

13 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.